{"id":"https://openalex.org/W1969006368","doi":"https://doi.org/10.3310/hta8050","title":"Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda\u00ae) for locally advanced and/or metastatic breast cancer","display_name":"Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda\u00ae) for locally advanced and/or metastatic breast cancer","alternate_titles":[],"publication_year":2004,"publication_date":"2004-02-01","ids":{"openalex":"https://openalex.org/W1969006368","doi":"https://doi.org/10.3310/hta8050","mag":"1969006368","pmid":"https://pubmed.ncbi.nlm.nih.gov/14960257"},"language":"en","primary_location":{"id":"doi:10.3310/hta8050","doi":"https://doi.org/10.3310/hta8050","is_oa":true,"landing_page_url":"https://doi.org/10.3310/hta8050","pdf_url":null,"source":{"id":"https://openalex.org/S191206091","display_name":"Health Technology Assessment","issn_l":"1366-5278","issn":["1366-5278","2046-4924","2046-4932"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311817","host_organization_name":"NIHR Journals Library","host_organization_lineage":["https://openalex.org/P4310311817"],"host_organization_lineage_names":["NIHR Journals Library"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Technology Assessment","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1969006368"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.3310/hta8050","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038983697","display_name":"Lisa Jones","orcid":"https://orcid.org/0000-0001-5136-5614","observed_orcids":["https://orcid.org/0000-0001-5136-5614"]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L Jones","raw_affiliation_strings":["NHS Centre for Reviews and Dissemination, University of York, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NHS Centre for Reviews and Dissemination, University of York, UK","institution_ids":["https://openalex.org/I52099693"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003412990","display_name":"Neil Hawkins","orcid":"https://orcid.org/0000-0003-3199-221X","observed_orcids":["https://orcid.org/0000-0003-3199-221X"]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"N Hawkins","raw_affiliation_strings":["Centre for Health Economics, University of York, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Health Economics, University of York, UK","institution_ids":["https://openalex.org/I52099693"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074205715","display_name":"Marie E. Westwood","orcid":"https://orcid.org/0000-0002-6257-0653","observed_orcids":["https://orcid.org/0000-0002-6257-0653"]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M Westwood","raw_affiliation_strings":["NHS Centre for Reviews and Dissemination, University of York, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NHS Centre for Reviews and Dissemination, University of York, UK","institution_ids":["https://openalex.org/I52099693"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070161423","display_name":"Kath E. Wright","orcid":"https://orcid.org/0000-0002-9020-1572","observed_orcids":["https://orcid.org/0000-0002-9020-1572"]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"K Wright","raw_affiliation_strings":["NHS Centre for Reviews and Dissemination, University of York, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NHS Centre for Reviews and Dissemination, University of York, UK","institution_ids":["https://openalex.org/I52099693"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010965225","display_name":"Gary Edward Richardson","orcid":"https://orcid.org/0000-0003-2122-8285","observed_orcids":["https://orcid.org/0000-0003-2122-8285"]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G Richardson","raw_affiliation_strings":["Centre for Health Economics, University of York, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Health Economics, University of York, UK","institution_ids":["https://openalex.org/I52099693"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029658912","display_name":"Robert P. Riemsma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52099693","display_name":"University of York","ror":"https://ror.org/04m01e293","country_code":"GB","type":"education","lineage":["https://openalex.org/I52099693"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R Riemsma","raw_affiliation_strings":["NHS Centre for Reviews and Dissemination, University of York, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NHS Centre for Reviews and Dissemination, University of York, UK","institution_ids":["https://openalex.org/I52099693"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I52099693"],"apc_list":null,"apc_paid":null,"fwci":2.0217,"has_fulltext":false,"cited_by_count":89,"citation_normalized_percentile":{"value":0.85072245,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"8","issue":"5","first_page":"iii, xiii","last_page":"xvi, 1"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.8130000233650208,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.8130000233650208,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.14159999787807465,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.024299999698996544,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/capecitabine","display_name":"capecitabine","score":1.0},{"id":"https://openalex.org/keywords/locally-advanced-breast-cancer","display_name":"locally advanced breast cancer","score":0.875},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8799999952316284},{"id":"https://openalex.org/keywords/clinical-effectiveness","display_name":"clinical effectiveness","score":0.878000020980835},{"id":"https://openalex.org/keywords/docetaxel-combination-therapy","display_name":"docetaxel combination therapy","score":0.8579999804496765},{"id":"https://openalex.org/keywords/vinorelbine","display_name":"vinorelbine","score":0.8330000042915344},{"id":"https://openalex.org/keywords/hand-foot-syndrome","display_name":"hand-foot syndrome","score":0.9449999928474426},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5590000152587891},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.7480000257492065},{"id":"https://openalex.org/keywords/oral-chemotherapy","display_name":"oral chemotherapy","score":0.4390000104904175}],"concepts":[{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.9492855072021484},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8831278085708618},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.8249365091323853},{"id":"https://openalex.org/C2780350996","wikidata":"https://www.wikidata.org/wiki/Q420532","display_name":"Vinorelbine","level":4,"score":0.7005488276481628},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.634791374206543},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5983937978744507},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5806381702423096},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.5401571989059448},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.5079212784767151},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5019204616546631},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.48448988795280457},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4757244884967804},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4347125291824341},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.4321085512638092},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.245733380317688},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1650632917881012},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.11493048071861267},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.0},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069287","descriptor_name":"Capecitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077143","descriptor_name":"Docetaxel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D006113","descriptor_name":"United Kingdom","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013222","descriptor_name":"State Medicine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043823","descriptor_name":"Taxoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.3310/hta8050","doi":"https://doi.org/10.3310/hta8050","is_oa":true,"landing_page_url":"https://doi.org/10.3310/hta8050","pdf_url":null,"source":{"id":"https://openalex.org/S191206091","display_name":"Health Technology Assessment","issn_l":"1366-5278","issn":["1366-5278","2046-4924","2046-4932"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311817","host_organization_name":"NIHR Journals Library","host_organization_lineage":["https://openalex.org/P4310311817"],"host_organization_lineage_names":["NIHR Journals Library"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Technology Assessment","raw_type":"journal-article"},{"id":"pmid:14960257","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14960257","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health technology assessment (Winchester, England)","raw_type":"Comparative Study"},{"id":"pmh:oai:research-information.bris.ac.uk:openaire_cris_publications/56fadfce-2707-4af8-ae0e-a79f0d59bc9f","doi":null,"is_oa":false,"landing_page_url":"https://research-information.bris.ac.uk/en/publications/56fadfce-2707-4af8-ae0e-a79f0d59bc9f","pdf_url":null,"source":{"id":"https://openalex.org/S4306400895","display_name":"Bristol Research (University of Bristol)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I36234482","host_organization_name":"University of Bristol","host_organization_lineage":["https://openalex.org/I36234482"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Jones, L, Hawkins, N, Westwood, M, Wright, K, Richardson, G & Riemsma, R 2004, 'Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda) for locally advanced and/or metastatic breast cancer.', Health technology assessment (Winchester, England). https://doi.org/10.3310/hta8050","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:researchonline.lshtm.ac.uk:2534908","doi":null,"is_oa":false,"landing_page_url":"https://researchonline.lshtm.ac.uk/id/eprint/2534908/","pdf_url":null,"source":{"id":"https://openalex.org/S4306402527","display_name":"LSHTM Research Online (London School of Hygiene and Tropical Medicine)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210089966","host_organization_name":"London School of Hygiene & Tropical Medicine","host_organization_lineage":["https://openalex.org/I4210089966"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:doaj.org/article:da543fa259174d16b6dfb64239e9f2c7","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/da543fa259174d16b6dfb64239e9f2c7","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Health Technology Assessment, Vol 8, Iss 5 (2004)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3310/hta8050","doi":"https://doi.org/10.3310/hta8050","is_oa":true,"landing_page_url":"https://doi.org/10.3310/hta8050","pdf_url":null,"source":{"id":"https://openalex.org/S191206091","display_name":"Health Technology Assessment","issn_l":"1366-5278","issn":["1366-5278","2046-4924","2046-4932"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311817","host_organization_name":"NIHR Journals Library","host_organization_lineage":["https://openalex.org/P4310311817"],"host_organization_lineage_names":["NIHR Journals Library"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Health Technology Assessment","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[{"id":"https://openalex.org/G7875367713","display_name":null,"funder_award_id":"01/57/01","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G8674889147","display_name":null,"funder_award_id":"01/57/01","funder_id":"https://openalex.org/F4320334661","funder_display_name":"Health Technology Assessment Programme"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320334661","display_name":"Health Technology Assessment Programme","ror":"https://ror.org/0187kwz08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":99,"referenced_works":["https://openalex.org/W8367052","https://openalex.org/W26253050","https://openalex.org/W63389338","https://openalex.org/W67473903","https://openalex.org/W73784268","https://openalex.org/W74385408","https://openalex.org/W196887982","https://openalex.org/W1525210877","https://openalex.org/W1550397976","https://openalex.org/W1595046345","https://openalex.org/W1828283074","https://openalex.org/W1849818006","https://openalex.org/W1905936368","https://openalex.org/W1934919277","https://openalex.org/W1939003096","https://openalex.org/W1964239259","https://openalex.org/W1968242936","https://openalex.org/W1968602462","https://openalex.org/W1978791841","https://openalex.org/W1982182115","https://openalex.org/W1985312776","https://openalex.org/W1988290414","https://openalex.org/W1994561005","https://openalex.org/W1996848790","https://openalex.org/W2002295232","https://openalex.org/W2002432597","https://openalex.org/W2007141799","https://openalex.org/W2007483403","https://openalex.org/W2008863543","https://openalex.org/W2009283892","https://openalex.org/W2011892983","https://openalex.org/W2013674078","https://openalex.org/W2013754529","https://openalex.org/W2015159040","https://openalex.org/W2025258318","https://openalex.org/W2044647580","https://openalex.org/W2044970916","https://openalex.org/W2045259489","https://openalex.org/W2050013638","https://openalex.org/W2060897854","https://openalex.org/W2064232761","https://openalex.org/W2068002016","https://openalex.org/W2077637101","https://openalex.org/W2080725243","https://openalex.org/W2081040380","https://openalex.org/W2087234093","https://openalex.org/W2090355800","https://openalex.org/W2092836522","https://openalex.org/W2100230735","https://openalex.org/W2100471203","https://openalex.org/W2102643038","https://openalex.org/W2103221219","https://openalex.org/W2103953671","https://openalex.org/W2123732467","https://openalex.org/W2130364126","https://openalex.org/W2131770017","https://openalex.org/W2133615960","https://openalex.org/W2134032079","https://openalex.org/W2135378470","https://openalex.org/W2141375105","https://openalex.org/W2142533861","https://openalex.org/W2142890220","https://openalex.org/W2159358778","https://openalex.org/W2162819176","https://openalex.org/W2165757143","https://openalex.org/W2171172959","https://openalex.org/W2203599654","https://openalex.org/W2247767239","https://openalex.org/W2259233362","https://openalex.org/W2314318352","https://openalex.org/W2323433130","https://openalex.org/W2331535673","https://openalex.org/W2339758211","https://openalex.org/W2396682127","https://openalex.org/W2399304372","https://openalex.org/W2409334201","https://openalex.org/W2409911594","https://openalex.org/W2414159307","https://openalex.org/W2415338728","https://openalex.org/W2415797588","https://openalex.org/W2417368681","https://openalex.org/W2419122554","https://openalex.org/W2419348155","https://openalex.org/W2435663671","https://openalex.org/W2437204367","https://openalex.org/W2464140490","https://openalex.org/W2472708732","https://openalex.org/W2473956190","https://openalex.org/W2474198432","https://openalex.org/W2478829584","https://openalex.org/W2599228863","https://openalex.org/W2602676801","https://openalex.org/W2737206118","https://openalex.org/W2742618561","https://openalex.org/W2802499330","https://openalex.org/W4230720275","https://openalex.org/W4244122550","https://openalex.org/W4253775372","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W7024126396","https://openalex.org/W2100199857","https://openalex.org/W4244359588","https://openalex.org/W1522433939","https://openalex.org/W3087403018","https://openalex.org/W2365660359","https://openalex.org/W327522589","https://openalex.org/W2157642679","https://openalex.org/W2098169322","https://openalex.org/W2350672523"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"examine":[2],"the":[3,105,122,147,151,230,249,253],"clinical":[4],"effectiveness":[5],"and":[6,14,29,35,42,51,64,140,165,194,271,287],"cost-effectiveness":[7],"of":[8,32,39,121,137,150,188,233,252,282],"oral":[9],"capecitabine":[10,69,82,110,159,170,234],"for":[11,214],"locally":[12],"advanced":[13],"metastatic":[15],"breast":[16],"cancer":[17],"in":[18,71,83,87,104,171,186,221],"relation":[19],"to":[20,183,191,273],"its":[21],"licensed":[22],"indications.":[23],"DATA":[24],"SOURCES:":[25],"Twenty-three":[26],"electronic":[27],"databases":[28,31],"other":[30],"ongoing":[33],"research":[34],"Internet":[36],"resources,":[37],"bibliographies":[38],"retrieved":[40],"articles":[41],"industry":[43],"submissions.":[44],"REVIEW":[45],"METHODS:":[46],"Two":[47],"reviewers":[48],"independently":[49],"screened":[50],"assessed":[52],"all":[53],"titles":[54],"and/or":[55],"abstracts":[56],"including":[57],"economic":[58,97,206],"evaluations.":[59],"Randomised":[60],"controlled":[61],"trials":[62,254],"(RCTs)":[63],"observational":[65,114],"studies":[66,115,123],"that":[67],"investigated":[68],"monotherapy,":[70,111],"patients":[72,88],"pretreated":[73,89],"with":[74,85,90,133,157,162,173,202,217,243,279],"an":[75,91,209],"anthracycline-containing":[76,92],"regimen":[77],"or":[78,81],"a":[79,134,218],"taxane,":[80],"combination":[84,172,203,215,263],"docetaxel,":[86,174],"regimen,":[93],"were":[94,116],"included.":[95],"The":[96,118,205],"evaluation":[98,143,207],"was":[99,124,131,144,160,177,181,265,277],"based":[100],"on":[101,260],"data":[102],"reported":[103],"manufacturer's":[106],"submission.":[107],"RESULTS:":[108],"For":[109,169],"12":[112],"uncontrolled":[113],"identified.":[117,178],"methodological":[119],"quality":[120,149,251],"low.":[125],"Capecitabine":[126,239],"demonstrated":[127,208],"antitumour":[128],"activity,":[129],"but":[130,154,245,276],"associated":[132,161,278],"particular":[135],"risk":[136],"hand-foot":[138,283],"syndrome":[139],"diarrhoea.":[141],"Economic":[142],"hampered":[145],"by":[146],"poor":[148,250],"published":[152],"studies,":[153],"compared":[155,242],"indirectly":[156],"vinorelbine,":[158,244],"lower":[163],"costs":[164],"improved":[166,211],"patient":[167],"outcomes.":[168],"one":[175],"RCT":[176],"Combination":[179],"therapy":[180,216,264],"superior":[182],"single-agent":[184,269],"docetaxel":[185,270],"terms":[187],"survival,":[189],"time":[190],"disease":[192],"progression":[193],"overall":[195,210],"response.":[196],"Adverse":[197],"events":[198],"occurred":[199],"more":[200,266],"frequently":[201],"therapy.":[204],"QALY":[212],"score":[213],"slight":[219],"reduction":[220],"costs.":[222],"CONCLUSIONS:":[223],"No":[224],"conclusions":[225],"could":[226],"be":[227,274],"drawn":[228],"regarding":[229],"therapeutic":[231],"benefit":[232],"monotherapy;":[235],"RCTs":[236],"are":[237],"required.":[238],"appeared":[240],"cost-effective":[241],"serious":[246],"doubts":[247],"remain;":[248],"may":[255],"invalidate":[256],"this":[257],"conclusion.":[258],"Based":[259],"limited":[261],"evidence,":[262],"effective":[267],"than":[268],"likely":[272],"cost-effective,":[275],"higher":[280],"incidences":[281],"syndrome,":[284],"nausea,":[285],"diarrhoea":[286],"stomatitis.":[288]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1969006368","counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
